Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats.
about
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarinCannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammationAlternative targets within the endocannabinoid system for future treatment of gastrointestinal diseasesPolyunsaturated Fatty Acids and Their Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal Disorders, and Colorectal CancerPharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndromeCannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated ratsRole of Cannabinoids in Gastrointestinal Mucosal Defense and InflammationStress and visceral pain: from animal models to clinical therapiesCannabinoid agonists inhibit neuropathic pain induced by brachial plexus avulsion in mice by affecting glial cells and MAP kinases.The role of peripheral cannabinoid receptors type 1 in rats with visceral hypersensitivity induced by chronic restraint stress.Differential effects of CB(1) neutral antagonists and inverse agonists on gastrointestinal motility in mice.The role of cannabinoids in regulation of nausea and vomiting, and visceral pain.Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities.Cannabinoid receptor 1 gene and irritable bowel syndrome: phenotype and quantitative traitsThe cannabinoid CB(2) receptor: a good friend in the gut.Endocannabinoids and the gastrointestinal tract: what are the key questions?In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat.Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea.Role of cannabinoid receptors in the control of gastrointestinal motility and perception.Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery.Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN.Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies.Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not "higher".Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance.Endocannabinoids in the gastrointestinal tract.Cannabinoids and GI Disorders: Endogenous and Exogenous.Complementary Therapies in Inflammatory Bowel Diseases.Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease.Evidence for a novel functional role of cannabinoid CB(2) receptors in the thalamus of neuropathic rats.The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents.Small intestinal cannabinoid receptor changes following a single colonic insult with oil of mustard in mice.Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation.Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study.Endocannabinoid-related compounds in gastrointestinal diseases.Dronabinol increases pain threshold in patients with functional chest pain: a pilot double-blind placebo-controlled trial.Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study.Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome.Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis.
P2860
Q24643876-69824AE3-E4A5-49D7-9D92-3140790B1C78Q24643922-F881D09A-BF1A-4419-9388-A56CFD55E979Q26824588-358C7266-0F93-4955-A285-C6DF00FF2CA3Q28071957-3D0CB701-3EF4-41B3-9DDE-55BB3AF387AFQ28244460-367A1F75-7989-4FDC-A2A0-A7DC54B1C33DQ28568772-792F617E-1822-4EAC-927D-CDDD23DFC080Q30357558-EC8CB972-11D5-4D6A-A8DD-55D2E63137D0Q30459512-B79CF9A2-EA9B-400E-B16D-BA2879D00E22Q34023238-C92868CE-7B77-4659-A81C-EA995B5FE738Q34028431-8C11622F-B591-4110-B767-ADBC49394D89Q34145142-1A616E82-EF93-4A4E-B837-4F32DA377522Q34464535-1B227551-DD70-4726-9716-A8C010DBEA89Q35087100-5204FDEC-BF15-4CC1-8BFA-EBA411B92459Q36699687-5174DD15-AE89-4F55-B63E-0D8BD5A633FDQ36922349-121398DF-A79B-4245-873B-21371C4D6FCCQ36927486-E84ED0BB-20B1-4EAD-995D-7EC7DEAA5831Q37032490-747E0828-D09F-4FBC-87EC-658EC7C03801Q37178858-BFECD6DA-C7D3-41D2-B1EC-AD1AE03818C5Q37345943-7A2954AB-A9C5-486A-B913-3FEEAD8AA432Q37721641-2669A6D7-4DF2-4611-8465-BFAA36A42DA5Q37827687-081EE594-FF60-48D2-AA84-87E608692C0DQ37960078-843B0696-EC42-4C6C-B958-6163A98EB990Q38196875-FDBD9935-8CF3-4125-B5C1-26BB0CCADA20Q38503842-29E09C4C-9653-4A28-A0F5-71859C575DEEQ38761437-B8E709AB-3183-4416-8B01-D4B1E2E9CEF7Q38931168-9C10F6AD-C93C-4E69-B5AB-6196DDF5F150Q38971616-F2C8D024-205E-490B-BC13-581105FEA7D9Q38982194-3630327D-107A-4603-BCDD-27839D289E7DQ39213927-173D85FA-A775-48F4-A1DF-73AA81904A1BQ42217054-E2408D80-8CD4-41E4-ACC9-EBBE893C22BCQ42702028-FFBA5152-E3EC-4338-B4F7-E477E8645EDCQ42730246-4E7A8C65-0953-4DAA-8278-E4DCF771838FQ46930478-4297D4E3-4E79-4411-BD05-834F0438EA39Q47343398-66E10B4D-F31C-4842-856D-55B34043511CQ47839554-9F04045B-4C52-4520-9D96-1D405862B7DDQ48065211-BC4BF74C-E2C2-4B49-A2FB-9C7D8A6C36A0Q48223585-CC23E209-BBE0-450E-BE60-4A4324FA1842Q54227125-FE155066-AC15-4E9E-8766-898CC2C68303Q54273247-A9152D60-ECF9-47D7-9AB6-D317AF5D6B73
P2860
Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Involvement of cannabinoid rec ...... to colonic distension in rats.
@en
Involvement of cannabinoid rec ...... to colonic distension in rats.
@nl
type
label
Involvement of cannabinoid rec ...... to colonic distension in rats.
@en
Involvement of cannabinoid rec ...... to colonic distension in rats.
@nl
prefLabel
Involvement of cannabinoid rec ...... to colonic distension in rats.
@en
Involvement of cannabinoid rec ...... to colonic distension in rats.
@nl
P2093
P2860
P921
P1476
Involvement of cannabinoid rec ...... to colonic distension in rats.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2982.2006.00819.X
P577
2006-10-01T00:00:00Z